ACUTE KIDNEY GRAFT-REJECTION - A MORPHOLOGICAL AND IMMUNOHISTOLOGICALSTUDY ON ZERO-HOUR AND FOLLOW-UP BIOPSIES WITH SPECIAL EMPHASIS ON CELLULAR INFILTRATES AND ADHESION MOLECULES
Cb. Andersen et al., ACUTE KIDNEY GRAFT-REJECTION - A MORPHOLOGICAL AND IMMUNOHISTOLOGICALSTUDY ON ZERO-HOUR AND FOLLOW-UP BIOPSIES WITH SPECIAL EMPHASIS ON CELLULAR INFILTRATES AND ADHESION MOLECULES, APMIS. Acta pathologica, microbiologica et immunologica Scandinavica, 102(1), 1994, pp. 23-37
Serial biopsies from 41 consecutive renal allotransplanted patients we
re evaluated in order to obtain pretransplant data as well as informat
ion on well-functioning and acutely rejecting grafts. Each patient ser
ved as his own control. Thirty-five patients were followed according t
o the schedule which included biopsy prior to transplantation, shortly
after opening of reanastomosis, at least once postoperatively (days 7
-10), and furthermore whenever clinically indicated. The morphological
evaluation was in each case combined with immunofluorescence (to dete
ct immunoglobulins and complement fractions) and immunohistochemistry
with a wide panel of monoclonal antibodies for T cells (CD2, CD3, CD4,
CD8, gamma delta), B cells (CD20, CD22), macrophages (CD68, MAC387) N
K cells (leu-7, CD16), activation markers (IL-2-R, Ki-67, transferrin-
R), MHC antigens (HLA-ABC, HLA-DR), adhesion molecules (ICAM-1, VCAM-1
, ELAM-1, PADGEM, VLA-4, LFA-1 alpha/beta), and growth factors (EGF, T
GF-alpha EGF-R). When 132 biopsies and 10 failed allografts were exami
ned, no specific morphological or immunohistological parameter predict
ive of rejection or graft outcome could be found. Morphology in follow
-up biopsies from non-rejecting and rejecting patients revealed a cont
inuum of inflammatory changes, and several non-rejecting cases demonst
rated cellular inflammatory infiltrates which could not be discriminat
ed from those seen in acute rejection. Of the patients 44% had acute r
ejection accompanied by increased infiltration of T cells and macropha
ges showing enhanced IL-2-R expression, increased tubular and endothel
ial staining for MHC class II, ICAM-1, and VCAM-1, and strong leukocyt
ic expression of VLA-4 and LFA-1 alpha/beta.